Sign in

CIK 0000875045

  • Large accelerated filer

BIOGEN INC.

Sign in to watch
Ticker
BIIB
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
330112644
Phone
+1 617-679-2000
Business address
225 BINNEY STREET, CAMBRIDGE, MA, 02142
Former names
BIOGEN IDEC INC., BIOGEN IDEC INC, IDEC PHARMACEUTICALS CORP / DE, IDEC PHARMACEUTICALS CORP / CA
  1. 4 Derivatives Options or other derivatives
  2. 4 Shares withheld for taxes EVP, Chief Medical Officer gave up 1,316 shares (to pay taxes)
  3. 4 Open-market sale Director sold 5,832 shares at $329.65 ($1,922,519)
  4. 4/A Derivatives Options or other derivatives
  5. 4 Derivatives Options or other derivatives
  6. 4 Open-market buy Chief Executive Officer bought 780 shares at $320.55 ($250,029)
  7. 3 Insider Initial Statement of Ownership
  8. 4 Grant or award EVP Glob. Mkt Acc & Cust Innov acquired 2,350 shares (grant or award)
  9. 4 Shares withheld for taxes VP, Chief Accounting Officer gave up 157 shares (to pay taxes)
  10. 4 Gift Director gave 850 shares (gift)
  11. 4 Open-market buy Director bought 30,000 shares at an average $317.36 ($9,520,800)
  12. 3 Insider Initial Statement of Ownership
  13. 4 Insider Changes in Ownership
  14. 4 Insider Changes in Ownership
  15. 4 Insider Changes in Ownership
  16. 4 Insider Changes in Ownership
  17. 3 Insider Initial Statement of Ownership
  18. 4 Insider Changes in Ownership
  19. 3 Insider Initial Statement of Ownership
  20. 4 Insider Changes in Ownership

Page 22 of 86 · 1,714 filings